TRAINING REAXYS MEDICINAL CHEMISTRY

Reaxys Medicinal Chemistry Fact Sheet

R&D SOLUTIONS FOR PHARMA & LIFE SCIENCES Reaxys Medicinal Chemistry Fact Sheet Essential data for lead identification and optimization Reaxys Medicinal Chemistry empowers early discovery in drug development

DRUG DISCOVERY TODAY ELN ELN. Chemistry. Biology. Known ligands. DBs. Generate chemistry ideas. Check chemical feasibility In-house.

DRUG DISCOVERY TODAY Known ligands Chemistry ELN DBs Knowledge survey Therapeutic target Generate chemistry ideas Check chemical feasibility In-house Analyze SAR Synthesize or buy Report Test Journals

PIOTR GOLKIEWICZ LIFE SCIENCES SOLUTIONS CONSULTANT CENTRAL-EASTERN EUROPE

PIOTR GOLKIEWICZ LIFE SCIENCES SOLUTIONS CONSULTANT CENTRAL-EASTERN EUROPE 1 SERVING THE LIFE SCIENCES SPACE ADDRESSING KEY CHALLENGES ACROSS THE R&D VALUE CHAIN Characterize targets & analyze disease

In silico pharmacology for drug discovery

In silico pharmacology for drug discovery In silico drug design In silico methods can contribute to drug targets identification through application of bionformatics tools. Currently, the application of

In Silico Investigation of Off-Target Effects

PHARMA & LIFE SCIENCES WHITEPAPER In Silico Investigation of Off-Target Effects STREAMLINING IN SILICO PROFILING In silico techniques require exhaustive data and sophisticated, well-structured informatics

The shortest path to chemistry data and literature

R&D SOLUTIONS Reaxys Fact Sheet The shortest path to chemistry data and literature Designed to support the full range of chemistry research, including pharmaceutical development, environmental health &

Reaxys The Highlights

Reaxys The Highlights What is Reaxys? A brand new workflow solution for research chemists and scientists from related disciplines An extensive repository of reaction and substance property data A resource

Receptor Based Drug Design (1)

Induced Fit Model For more than 100 years, the behaviour of enzymes had been explained by the "lock-and-key" mechanism developed by pioneering German chemist Emil Fischer. Fischer thought that the chemicals

Introduction to Chemoinformatics and Drug Discovery

Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013 The Chemical Space There are atoms and space. Everything else is opinion. Democritus (ca.

Integrated Cheminformatics to Guide Drug Discovery

Integrated Cheminformatics to Guide Drug Discovery Matthew Segall, Ed Champness, Peter Hunt, Tamsin Mansley CINF Drug Discovery Cheminformatics Approaches August 23 rd 2017 Optibrium, StarDrop, Auto-Modeller,

Computational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007

Computational Chemistry in Drug Design Xavier Fradera Barcelona, 17/4/2007 verview Introduction and background Drug Design Cycle Computational methods Chemoinformatics Ligand Based Methods Structure Based

Early Stages of Drug Discovery in the Pharmaceutical Industry

Early Stages of Drug Discovery in the Pharmaceutical Industry Daniel Seeliger / Jan Kriegl, Discovery Research, Boehringer Ingelheim September 29, 2016 Historical Drug Discovery From Accidential Discovery

Capturing Chemistry. What you see is what you get In the world of mechanism and chemical transformations

Capturing Chemistry What you see is what you get In the world of mechanism and chemical transformations Dr. Stephan Schürer ead of Intl. Sci. Content Libraria, Inc. sschurer@libraria.com Distribution of

QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression

APPLICATION NOTE QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression GAINING EFFICIENCY IN QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS ErbB1 kinase is the cell-surface receptor

FRAUNHOFER IME SCREENINGPORT

FRAUNHOFER IME SCREENINGPORT Design of screening projects General remarks Introduction Screening is done to identify new chemical substances against molecular mechanisms of a disease It is a question of

The Case for Use Cases

The Case for Use Cases The integration of internal and external chemical information is a vital and complex activity for the pharmaceutical industry. David Walsh, Grail Entropix Ltd Costs of Integrating

CSD. Unlock value from crystal structure information in the CSD

CSD CSD-System Unlock value from crystal structure information in the CSD The Cambridge Structural Database (CSD) is the world s most comprehensive and up-todate knowledge base of crystal structure data,

CH MEDICINAL CHEMISTRY

CH 458 - MEDICINAL CHEMISTRY SPRING 2011 M: 5:15pm-8 pm Sci-1-089 Prerequisite: Organic Chemistry II (Chem 254 or Chem 252, or equivalent transfer course) Instructor: Dr. Bela Torok Room S-1-132, Science

MSc Drug Design. Module Structure: (15 credits each) Lectures and Tutorials Assessment: 50% coursework, 50% unseen examination.

Module Structure: (15 credits each) Lectures and Assessment: 50% coursework, 50% unseen examination. Module Title Module 1: Bioinformatics and structural biology as applied to drug design MEDC0075 In the

JCICS Major Research Areas

JCICS Major Research Areas Chemical Information Text Searching Structure and Substructure Searching Databases Patents George W.A. Milne C571 Lecture Fall 2002 1 JCICS Major Research Areas Chemical Computation

Chemists are from Mars, Biologists from Venus. Originally published 7th November 2006

Chemists are from Mars, Biologists from Venus Originally published 7th November 2006 Chemists are from Mars, Biologists from Venus Andrew Lemon and Ted Hawkins, The Edge Software Consultancy Ltd Abstract

Introduction to Chemoinformatics

Introduction to Chemoinformatics Dr. Igor V. Tetko Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH) Institute of Bioinformatics & Systems Biology (HMGU) Kyiv, 10 August

Principles of Drug Design

(16:663:502) Instructors: Longqin Hu and John Kerrigan Direct questions and enquiries to the Course Coordinator: Longqin Hu For more current information, please check WebCT at https://webct.rutgers.edu

Practical QSAR and Library Design: Advanced tools for research teams

DS QSAR and Library Design Webinar Practical QSAR and Library Design: Advanced tools for research teams Reservationless-Plus Dial-In Number (US): (866) 519-8942 Reservationless-Plus International Dial-In

October 6 University Faculty of pharmacy Computer Aided Drug Design Unit

October 6 University Faculty of pharmacy Computer Aided Drug Design Unit CADD@O6U.edu.eg CADD Computer-Aided Drug Design Unit The development of new drugs is no longer a process of trial and error or strokes

Cheminformatics Role in Pharmaceutical Industry. Randal Chen Ph.D. Abbott Laboratories Aug. 23, 2004 ACS

Cheminformatics Role in Pharmaceutical Industry Randal Chen Ph.D. Abbott Laboratories Aug. 23, 2004 ACS Agenda The big picture for pharmaceutical industry Current technological/scientific issues Types

Quantitative structure activity relationship and drug design: A Review

International Journal of Research in Biosciences Vol. 5 Issue 4, pp. (1-5), October 2016 Available online at http://www.ijrbs.in ISSN 2319-2844 Research Paper Quantitative structure activity relationship

Evidence for the Existence of Non-monotonic Dose-response: Does it or Doesn t it?

Evidence for the Existence of Non-monotonic Dose-response: Does it or Doesn t it? Scott M. Belcher, PhD University of Cincinnati Department of Pharmacology and Cell Biophysics Evidence for the Existence

Principles of Drug Design

Advanced Medicinal Chemistry II Principles of Drug Design Tentative Course Outline Instructors: Longqin Hu and John Kerrigan Direct questions and enquiries to the Course Coordinator: Longqin Hu I. Introduction

ToxiCat: Hybrid Named Entity Recognition services to support curation of the Comparative Toxicogenomic Database

ToxiCat: Hybrid Named Entity Recognition services to support curation of the Comparative Toxicogenomic Database Dina Vishnyakova 1,2, 4, *, Julien Gobeill 1,3,4, Emilie Pasche 1,2,3,4 and Patrick Ruch

Ignasi Belda, PhD CEO. HPC Advisory Council Spain Conference 2015

Ignasi Belda, PhD CEO HPC Advisory Council Spain Conference 2015 Business lines Molecular Modeling Services We carry out computational chemistry projects using our selfdeveloped and third party technologies

Overview. Database Overview Chart Databases. And now, a Few Words About Searching. How Database Content is Delivered

Databases Overview Database Overview Chart Databases ChemIndex / NCI Cancer and AIDS ChemACX The Merck Index Ashgate Drugs Traditional Chinese Medicines And now, a Few Words About Searching chemical structure

DiscoveryGate. One place for the answers you need. Chulalongkorn University, Thailand

DiscoveryGate One place for the answers you need Chulalongkorn University, Thailand Presented by: Doreen Tan Title: Product Sales Manager, Life Science Date: 1 Sep 2005 DiscoveryGate The DiscoveryGate

Marvin 5.4 A new generation of structure indexing at Elsevier. Dr. Michael Maier, Dr. Heike Nau, Elsevier

Marvin 5.4 A new generation of structure indexing at Elsevier Dr. Michael Maier, Dr. Heike Nau, Elsevier Agenda Elsevier: Reaxys database Compound classes Structure requirements Marvin 5.4 Decision process

Chemically Intelligent Experiment Data Management

Chemically Intelligent Experiment Data Management Offering tools specifically designed to optimize the workflow of synthetic, medicinal, process and analytical chemists, the E-WorkBook Suite delivers a

The Changing Requirements for Informatics Systems During the Growth of a Collaborative Drug Discovery Service Company. Sally Rose BioFocus plc

The Changing Requirements for Informatics Systems During the Growth of a Collaborative Drug Discovery Service Company Sally Rose BioFocus plc Overview History of BioFocus and acquisition of CDD Biological

Building innovative drug discovery alliances. Just in KNIME: Successful Process Driven Drug Discovery

Building innovative drug discovery alliances Just in KIME: Successful Process Driven Drug Discovery Berlin KIME Spring Summit, Feb 2016 Research Informatics @ Evotec Evotec s worldwide operations 2 Pharmaceuticals

ImprovIng ADmE ScrEEnIng productivity In Drug DIScovEry

Improving ADME Screening Productivity in Drug Discovery INTRODUCTION Improving the quality of the decisions made at the drug discovery stage can profoundly impact the efficiency of the drug discovery and

Reaxys Managing Complexity

June 2009 Reaxys Managing Complexity Dr. Jürgen Swienty-Busch (j.swienty-busch@elsevier.com) What is Reaxys? Reaxys is Chemistry Covering more than 200 years of organic, organometallic and inorganic chemistry

Using AutoDock for Virtual Screening

Using AutoDock for Virtual Screening CUHK Croucher ASI Workshop 2011 Stefano Forli, PhD Prof. Arthur J. Olson, Ph.D Molecular Graphics Lab Screening and Virtual Screening The ultimate tool for identifying

Handling Human Interpreted Analytical Data. Workflows for Pharmaceutical R&D. Presented by Peter Russell

Handling Human Interpreted Analytical Data Workflows for Pharmaceutical R&D Presented by Peter Russell 2011 Survey 88% of R&D organizations lack adequate systems to automatically collect data for reporting,

Introducing a Bioinformatics Similarity Search Solution

Introducing a Bioinformatics Similarity Search Solution 1 Page About the APU 3 The APU as a Driver of Similarity Search 3 Similarity Search in Bioinformatics 3 POC: GSI Joins Forces with the Weizmann Institute

ASSESSING THE DRUG ABILITY OF CHALCONES USING IN- SILICO TOOLS

Page109 IJPBS Volume 5 Issue 1 JAN-MAR 2015 109-114 Research Article Pharmaceutical Sciences ASSESSING THE DRUG ABILITY OF CHALCONES USING IN- SILICO TOOLS Department of Pharmaceutical Chemistry, Institute

Product Guide. Thermo Scientific Cellomics HCS Solution

Product Guide Thermo Scientific Cellomics HCS Solution Thermo Scientific Cellomics HCS Solution Your Complete HCS Solution The search for new therapies for human diseases is increasingly driven by the

A powerful site for all chemists CHOICE CRC Handbook of Chemistry and Physics

Chemical Databases Online A powerful site for all chemists CHOICE CRC Handbook of Chemistry and Physics Combined Chemical Dictionary Dictionary of Natural Products Dictionary of Organic Dictionary of Drugs

Virtual screening in drug discovery

Virtual screening in drug discovery Pavel Polishchuk Institute of Molecular and Translational Medicine Palacky University pavlo.polishchuk@upol.cz Drug development workflow Vistoli G., et al., Drug Discovery

EMPIRICAL VS. RATIONAL METHODS OF DISCOVERING NEW DRUGS

EMPIRICAL VS. RATIONAL METHODS OF DISCOVERING NEW DRUGS PETER GUND Pharmacopeia Inc., CN 5350 Princeton, NJ 08543, USA pgund@pharmacop.com Empirical and theoretical approaches to drug discovery have often

Chemical Data Retrieval and Management

Chemical Data Retrieval and Management ChEMBL, ChEBI, and the Chemistry Development Kit Stephan A. Beisken What is EMBL-EBI? Part of the European Molecular Biology Laboratory International, non-profit

Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining

Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining Samer Haidar 1, Zouhair Bouaziz 2, Christelle Marminon 2, Tiomo Laitinen 3, Anti Poso

Reaxys Improved synthetic planning with Reaxys

R&D SOLUTIONS Reaxys Improved synthetic planning with Reaxys Integration of custom inventory and supplier catalogs in Reaxys helps chemists overcome challenges in planning chemical synthesis due to the

COMBINATORIAL CHEMISTRY IN A HISTORICAL PERSPECTIVE

NUE FEATURE T R A N S F O R M I N G C H A L L E N G E S I N T O M E D I C I N E Nuevolution Feature no. 1 October 2015 Technical Information COMBINATORIAL CHEMISTRY IN A HISTORICAL PERSPECTIVE A PROMISING

Kalexsyn Overview Kalexsyn, Inc Campus Drive Kalamazoo, MI Phone: (269) Fax: (269)

Kalexsyn verview 2017 Kalexsyn, Inc. 4502 Campus Drive Kalamazoo, MI 49008 Phone: (269) 488-8488 Fax: (269) 488-8490 info@kalexsyn.com What we are Experienced medicinal chemists Conception and synthesis

Cheminformatics platform for drug discovery application

EGI-InSPIRE Cheminformatics platform for drug discovery application Hsi-Kai, Wang Academic Sinica Grid Computing EGI User Forum, 13, April, 2011 1 Introduction to drug discovery Computing requirement of

Everyday NMR. Innovation with Integrity. Why infer when you can be sure? NMR

Everyday NMR Why infer when you can be sure? Innovation with Integrity NMR Only NMR gives you definitive answers, on your terms. Over the past half-century, scientists have used nuclear magnetic resonance

DiscoveryGate databases content

DiscoveryGate databases content * Compound Index contains molecules indexed in the following databases Reference Databases CrossFire Beilstein CrossFire Gmelin Thomson Scientific Index Chemicus* Patent

Advanced Medicinal Chemistry SLIDES B

Advanced Medicinal Chemistry Filippo Minutolo CFU 3 (21 hours) SLIDES B Drug likeness - ADME two contradictory physico-chemical parameters to balance: 1) aqueous solubility 2) lipid membrane permeability

Using Web Technologies for Integrative Drug Discovery

Using Web Technologies for Integrative Drug Discovery Qian Zhu 1 Sashikiran Challa 1 Yuying Sun 3 Michael S. Lajiness 2 David J. Wild 1 Ying Ding 3 1 School of Informatics and Computing, Indiana University,

THE RELATIONSHIP BETWEEN NATURAL PRODUCTS AND SYNTHETIC. Poldhune Parc Owles, Carbis Bay, St. Ives, Cornwall TR26 2RE, UK.

THE RELATIONSHIP BETWEEN NATURAL PRODUCTS AND SYNTHETIC CHEMISTRY IN THE DISCOVERY PROCESS by Dr. Stephen Brewer Consultant, Bioproducts Technology Poldhune Parc Owles, Carbis Bay, St. Ives, Cornwall TR26

Retrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a

Retrieving hits through in silico screening and expert assessment M.. Drwal a,b and R. Griffith a a: School of Medical Sciences/Pharmacology, USW, Sydney, Australia b: Charité Berlin, Germany Abstract:

Biologically Relevant Molecular Comparisons. Mark Mackey

Biologically Relevant Molecular Comparisons Mark Mackey Agenda > Cresset Technology > Cresset Products > FieldStere > FieldScreen > FieldAlign > FieldTemplater > Cresset and Knime About Cresset > Specialist

Applying Bioisosteric Transformations to Predict Novel, High Quality Compounds

Applying Bioisosteric Transformations to Predict Novel, High Quality Compounds Dr James Chisholm,* Dr John Barnard, Dr Julian Hayward, Dr Matthew Segall*, Mr Edmund Champness*, Dr Chris Leeding,* Mr Hector

WALKUP LC/MS FOR PHARMACEUTICAL R&D

Pharmaceutical Workflow Solutions WALKUP LC/MS FOR PHARMACEUTICAL R&D Chemists, Peptide/Protein Chemists, Biologists, and Beyond MASSHUNTER WALKUP A Single User Interface for Robust and Reliable LC/MS

Plan. Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics.

Plan Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics. Exercise: Example and exercise with herg potassium channel: Use of

Validation of the GastroPlus TM Software Tool and Applications

Validation of the GastroPlus TM Software Tool and Applications Fagen Zhang and Leah Luna The Dow Chemical Company FZ/MB 01.11.11 Acknowledgements Michael Bartels Barun Bhhatarai (Novartis) Tyler Auernhammer

Introduction. OntoChem

Introduction ntochem Providing drug discovery knowledge & small molecules... Supporting the task of medicinal chemistry Allows selecting best possible small molecule starting point From target to leads

Reaxys Pipeline Pilot Components Installation and User Guide

1 1 Reaxys Pipeline Pilot components for Pipeline Pilot 9.5 Reaxys Pipeline Pilot Components Installation and User Guide Version 1.0 2 Introduction The Reaxys and Reaxys Medicinal Chemistry Application

Notes of Dr. Anil Mishra at 1

Introduction Quantitative Structure-Activity Relationships QSPR Quantitative Structure-Property Relationships What is? is a mathematical relationship between a biological activity of a molecular system

Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME

Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME Iván Solt Solutions for Cheminformatics Drug Discovery Strategies for known targets High-Throughput Screening (HTS) Cells

Dr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre

Dr. Sander B. Nabuurs Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre The road to new drugs. How to find new hits? High Throughput

ABI 3200 Q TRAP LC/MS/MS System

www.ietltd.com Proudly serving laboratories worldwide since 1979 CALL 001.847.913.0777 ABI 3200 Q TRAP LC/MS/MS System The advantages of an ion trap and the performance of a triple quad. All in one system.

MDL Databases. Solutions At Every Stage in the R&D Process. MDL Databases. Information Systems, Inc.

MDL Databases Solutions At Every Stage in the R&D Process MDL Databases Information Systems, Inc. Solutions At Every Stage in the R&D Process MDL Databases Many of the problems scientists encounter during

ADME SCREENING OF NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES

ITERATIAL JURAL F RESEARC I PARMACY AD CEMISTRY Available online at www.ijrpc.com Research Article ADME SCREEIG F VEL 1,4-DIYDRPYRIDIE DERIVATIVES A. Asma samaunnisa 1*, CS. Venkataramana 1 and V Madhavan

Design Drugs Collaboratively Using Spotfire Visualization and Analysis

Design Drugs Collaboratively Using Spotfire Visualization and Analysis Anthony Donofrio PKI Data Analysis & R&D Informatics East Coast User Conference GSK Upper Merion, PA 09/15/2016 Merck Research Laboratories

Next Generation Computational Chemistry Tools to Predict Toxicity of CWAs

Next Generation Computational Chemistry Tools to Predict Toxicity of CWAs William (Bill) Welsh welshwj@umdnj.edu Prospective Funding by DTRA/JSTO-CBD CBIS Conference 1 A State-wide, Regional and National

Chemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller

Chemogenomic: Approaches to Rational Drug Design Jonas Skjødt Møller Chemogenomic Chemistry Biology Chemical biology Medical chemistry Chemical genetics Chemoinformatics Bioinformatics Chemoproteomics

Design and Synthesis of the Comprehensive Fragment Library

YOUR INNOVATIVE CHEMISTRY PARTNER IN DRUG DISCOVERY Design and Synthesis of the Comprehensive Fragment Library A 3D Enabled Library for Medicinal Chemistry Discovery Warren S Wade 1, Kuei-Lin Chang 1,

Structure-Based Drug Discovery An Overview

Structure-Based Drug Discovery An Overview Edited by Roderick E. Hubbard University of York, Heslington, York, UK and Vernalis (R&D) Ltd, Abington, Cambridge, UK RSC Publishing Contents Chapter 1 3D Structure

Bioorganic & Medicinal Chemistry

Bioorganic & Medicinal Chemistry 20 (2012) 5324 5342 Contents lists available at SciVerse ScienceDirect Bioorganic & Medicinal Chemistry journal homepage: www.elsevier.com/locate/bmc Early phase drug discovery:

Course Plan for Pharmacy (Bachelor Program) No.: (2016/2017) Approved by Deans Council by decision (09/26/2016) dated (03/08/2016) )160) Credit Hours

Toward Excellence in AlZaytoonah University of Jordan Course for Bachelor program Course Development and Updating Procedures/ QF/47.E Course for Pharmacy (Bachelor Program) No.: (6/7) Approved by Deans

bcl::cheminfo Suite Enables Machine Learning-Based Drug Discovery Using GPUs Edward W. Lowe, Jr. Nils Woetzel May 17, 2012

bcl::cheminfo Suite Enables Machine Learning-Based Drug Discovery Using GPUs Edward W. Lowe, Jr. Nils Woetzel May 17, 2012 Outline Machine Learning Cheminformatics Framework QSPR logp QSAR mglur 5 CYP

Application integration: Providing coherent drug discovery solutions

Application integration: Providing coherent drug discovery solutions Mitch Miller, Manish Sud, LION bioscience, American Chemical Society 22 August 2002 Overview 2 Introduction: exploring application integration

PROVIDING CHEMINFORMATICS SOLUTIONS TO SUPPORT DRUG DISCOVERY DECISIONS

179 Molecular Informatics: Confronting Complexity, May 13 th - 16 th 2002, Bozen, Italy PROVIDING CHEMINFORMATICS SOLUTIONS TO SUPPORT DRUG DISCOVERY DECISIONS CARLETON R. SAGE, KEVIN R. HOLME, NIANISH

Chemoinformatics and information management. Peter Willett, University of Sheffield, UK

Chemoinformatics and information management Peter Willett, University of Sheffield, UK verview What is chemoinformatics and why is it necessary Managing structural information Typical facilities in chemoinformatics

Priority Setting of Endocrine Disruptors Using QSARs

Priority Setting of Endocrine Disruptors Using QSARs Weida Tong Manager of Computational Science Group, Logicon ROW Sciences, FDA s National Center for Toxicological Research (NCTR), U.S.A. Thanks for

Structural biology and drug design: An overview

Structural biology and drug design: An overview livier Taboureau Assitant professor Chemoinformatics group-cbs-dtu otab@cbs.dtu.dk Drug discovery Drug and drug design A drug is a key molecule involved

ADMET property estimation, oral bioavailability predictions, SAR elucidation, & QSAR model building software www.simulations-plus.com +1-661-723-7723 What is? is an advanced computer program that enables

Simulating the drug discovery pipeline: a Monte Carlo approach

Yu Journal of Cheminformatics 2012, 4:32 RESEARCH ARTICLE Open Access Simulating the drug discovery pipeline: a Monte Carlo approach Melvin J Yu Abstract Background: The early drug discovery phase in pharmaceutical

COMBINATORIAL CHEMISTRY: CURRENT APPROACH

COMBINATORIAL CHEMISTRY: CURRENT APPROACH Dwivedi A. 1, Sitoke A. 2, Joshi V. 3, Akhtar A.K. 4* and Chaturvedi M. 1, NRI Institute of Pharmaceutical Sciences, Bhopal, M.P.-India 2, SRM College of Pharmacy,

Solved and Unsolved Problems in Chemoinformatics

Solved and Unsolved Problems in Chemoinformatics Johann Gasteiger Computer-Chemie-Centrum University of Erlangen-Nürnberg D-91052 Erlangen, Germany Johann.Gasteiger@fau.de Overview objectives of lecture

Navigating between patents, papers, abstracts and databases using public sources and tools

Navigating between patents, papers, abstracts and databases using public sources and tools Christopher Southan 1 and Sean Ekins 2 TW2Informatics, Göteborg, Sweden, Collaborative Drug Discovery, North Carolina,

Course Specification Medicinal Chemistry-1

Quality Assurance Unit Faculty of Pharmacy-Assiut University Course Specification Medicinal Chemistry-1 Programme(s) on which the course is given: B. Sc. (Pharmaceutical science) Major or Minor element

The Institute of Cancer Research PHD STUDENTSHIP PROJECT PROPOSAL

The Institute of Cancer Research PHD STUDENTSHIP PROJECT PROPOSAL PROJECT DETAILS Project Title: Design and synthesis of libraries of bifunctional degraders for the discovery of new cancer targets SUPERVISORY

Data Mining in the Chemical Industry. Overview of presentation

Data Mining in the Chemical Industry Glenn J. Myatt, Ph.D. Partner, Myatt & Johnson, Inc. glenn.myatt@gmail.com verview of presentation verview of the chemical industry Example of the pharmaceutical industry

Erfassung und Speicherung von Forschungsdaten im Fachbereich Chemie

Erfassung und Speicherung von Forschungsdaten im Fachbereich Chemie Bereitstellung moderner Forschungsinfrastrukturen durch ein elektronisches Laborjournal mit Repositorium-Anbindung INSTITUTE OF ORGANIC

COMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS

COMPUTER AIDED DRUG DESIGN (CADD) AND DEVELOPMENT METHODS DRUG DEVELOPMENT Drug development is a challenging path Today, the causes of many diseases (rheumatoid arthritis, cancer, mental diseases, etc.)

Ákos Tarcsay CHEMAXON SOLUTIONS

Ákos Tarcsay CHEMAXON SOLUTIONS FINDING NOVEL COMPOUNDS WITH IMPROVED OVERALL PROPERTY PROFILES Two faces of one world Structure Footprint Linked Data Reactions Analytical Batch Phys-Chem Assay Project

Database Speaks. Ling-Kang Liu ( 劉陵崗 ) Institute of Chemistry, Academia Sinica Nangang, Taipei 115, Taiwan

Database Speaks Ling-Kang Liu ( 劉陵崗 ) Institute of Chemistry, Academia Sinica Nangang, Taipei 115, Taiwan Email: liuu@chem.sinica.edu.tw 1 OUTLINES -- Personal experiences Publication types Secondary publication

Virtual Screening: How Are We Doing?

Virtual Screening: How Are We Doing? Mark E. Snow, James Dunbar, Lakshmi Narasimhan, Jack A. Bikker, Dan Ortwine, Christopher Whitehead, Yiannis Kaznessis, Dave Moreland, Christine Humblet Pfizer Global

SciFinder The choice for chemistry research

SciFinder The choice for chemistry research October 25 th 28 th, 2016 Bucharest, Romania Veli-Pekka Hyttinen ACS International Ltd vhyttinen@cas.org Tetiana Khristova ACS International Ltd tkhristova@acsi.info

Molecular Dynamics Simulations in Drug Discovery. Thomas Fox Discovery Research Boehringer Ingelheim Pharma GmbH & Co KG April 2017

Molecular Dynamics Simulations in Drug Discovery Thomas Fox Discovery Research Boehringer Ingelheim Pharma GmbH & Co KG April 2017 Boehringer Ingelheim in brief Family-owned global corporation Founded